Amedisys Inc (AMED) Social Stream



Amedisys Inc (AMED): $94.02

0.10 (+0.11%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

Add AMED to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#13 of 75

in industry

AMEDISYS INC (AMED) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering AMEDISYS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 13 $235 $150 $204.666 $93.55 118.78%
2021-12-07 13 $235 $150 $205.5 $93.55 119.67%
2021-12-21 14 $235 $150 $206.076 $93.55 120.28%
2022-01-06 14 $230 $150 $203.384 $93.55 117.41%
2022-01-20 14 $230 $150 $202.23 $93.55 116.17%
2022-02-01 14 $230 $145 $199.461 $93.55 113.21%
2022-02-02 14 $230 $145 $199.692 $93.55 113.46%
2022-02-17 14 $230 $147 $197.923 $93.55 111.57%
2022-02-25 15 $230 $147 $195.928 $93.55 109.44%
2022-03-01 15 $230 $147 $190.357 $93.55 103.48%
2022-03-08 15 $230 $147 $191.642 $93.55 104.86%
2022-03-24 15 $230 $160 $192.714 $93.55 106%
2022-04-01 15 $230 $162 $194.142 $93.55 107.53%
2022-04-29 15 $230 $131 $190.785 $93.55 103.94%
2022-05-03 15 $221 $131 $185.857 $93.55 98.67%
2022-05-26 15 $221 $131 $183.357 $93.55 96%
2022-05-27 15 $221 $117 $182.357 $93.55 94.93%
2022-06-13 15 $221 $117 $179.357 $93.55 91.72%
2022-06-21 15 $221 $107 $178.642 $93.55 90.96%
2022-07-14 16 $221 $102 $164.733 $93.55 76.09%
2022-07-29 16 $221 $102 $160.133 $93.55 71.17%
2022-08-01 16 $200 $102 $154.866 $93.55 65.54%
2022-08-02 16 $200 $102 $152.2 $93.55 62.69%
2022-08-03 16 $200 $95 $146.533 $93.55 56.64%
2022-09-06 16 $200 $95 $147.133 $93.55 57.28%
2022-09-19 16 $200 $95 $147.933 $93.55 58.13%
2022-10-03 16 $200 $95 $145.933 $93.55 55.99%
2022-10-05 16 $200 $95 $145.266 $93.55 55.28%
2022-10-19 16 $190 $95 $141.933 $93.55 51.72%
2022-10-25 16 $190 $95 $141.266 $93.55 51.01%
2022-10-27 16 $190 $90 $140.466 $93.55 50.15%
2022-10-28 16 $190 $90 $135.933 $93.55 45.31%
2022-11-02 16 $190 $90 $127.733 $93.55 36.54%
2022-11-03 16 $190 $90 $125.785 $93.55 34.46%
2022-11-11 16 $190 $90 $124.785 $93.55 33.39%
2022-12-05 16 $190 $90 $122.642 $93.55 31.1%
2023-01-03 16 $190 $84 $122.214 $93.55 30.64%
2023-01-17 16 $190 $84 $121.428 $93.55 29.8%
2023-01-19 16 $190 $84 $120 $93.55 28.27%
2023-02-15 16 $190 $84 $118.142 $93.55 26.29%
2023-02-21 16 $190 $84 $118.928 $93.55 27.13%
2023-02-22 16 $190 $84 $116.571 $93.55 24.61%
2023-02-24 16 $190 $84 $116 $93.55 24%
2023-03-10 15 $130 $84 $110.923 $93.55 18.57%
2023-03-29 15 $130 $84 $108.384 $93.55 15.86%
2023-04-13 15 $130 $84 $107.23 $93.55 14.62%
2023-04-21 16 $130 $84 $105.785 $93.55 13.08%
2023-05-05 14 $120 $84 $99.416 $93.55 6.27%
2023-05-09 14 $125 $81 $98 $93.55 4.76%
2023-06-06 14 $120 $81 $96.5 $93.55 3.15%
2023-06-26 13 $115 $84 $96.75 $93.55 3.42%
2023-06-27 13 $115 $84 $98.166 $93.55 4.93%
2023-07-03 13 $115 $84 $99 $93.55 5.83%
2023-07-28 13 $115 $84 $99.25 $93.55 6.09%
2023-07-31 13 $115 $84 $100.666 $93.55 7.61%
2023-08-01 13 $115 $84 $101 $93.55 7.96%
2023-08-02 13 $115 $84 $101.545 $93.55 8.55%
2023-08-21 12 $115 $84 $101.545 $93.55 8.55%
2023-09-13 12 $115 $84 $100.272 $93.55 7.19%
2023-09-20 13 $115 $73 $98.083 $93.55 4.85%

The Trend in the Analyst Price Target


AMED's average price target has moved down $85.27 over the prior 16 months.

Over the past 50 weeks, AMED's average upside potential has been 21.52%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-10-05 16 200 95 145.266 99.75 45.63%
2022-10-25 16 190 95 141.266 101.91 38.62%
2023-07-03 13 115 84 99.000 91.35 8.37%
2023-09-01 12 115 84 100.272 93.85 6.84%
2023-09-15 13 115 73 98.083 93.73 4.64%

AMED Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.77 2 1 9 1 1 13

The Trend in the Broker Recommendations


Over the past 26 weeks, AMED's average broker recommendation rating worsened by 0.25.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AMED as an investment opportunity.

  • AMED has a greater number of analysts covering the stock than 6621.21% of stocks in the mid market cap category.
  • In the context of stocks in the mid market cap category, AMEDISYS INC's average analyst price target is higher than 6453.63% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, AMEDISYS INC's upside potential (average analyst target price relative to current price) is greater than 2513.38% of them.
  • AMED has a lower variance in analysts' estimates than -3496.28% of Healthcare stocks.

Stocks similar to AMEDISYS INC in the Healthcare industry regarding analyst recommendations and price targets are CHE, SEM, and MD.

Make investment decisions regarding AMED using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!